Siemens Fonds Invest GmbH Raises Stock Holdings in McKesson Corporation $MCK

Siemens Fonds Invest GmbH grew its position in shares of McKesson Corporation (NYSE:MCK) by 18.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,787 shares of the company’s stock after purchasing an additional 747 shares during the period. Siemens Fonds Invest GmbH’s holdings in McKesson were worth $3,960,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in MCK. Cullen Investment Group LTD. boosted its holdings in shares of McKesson by 550.4% in the 4th quarter. Cullen Investment Group LTD. now owns 4,670 shares of the company’s stock valued at $3,811,000 after purchasing an additional 3,952 shares during the last quarter. Pensionfund Sabic acquired a new stake in shares of McKesson in the fourth quarter valued at about $1,887,000. Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its stake in shares of McKesson by 18.8% during the third quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 10,009 shares of the company’s stock valued at $7,732,000 after purchasing an additional 1,585 shares during the period. Achmea Investment Management B.V. increased its stake in McKesson by 7.5% during the 3rd quarter. Achmea Investment Management B.V. now owns 61,287 shares of the company’s stock worth $47,347,000 after buying an additional 4,260 shares during the period. Finally, Investment Research Partners LLC purchased a new stake in shares of McKesson during the third quarter worth about $1,303,000. Institutional investors and hedge funds own 85.07% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on MCK. Bank of America cut their price target on shares of McKesson from $1,040.00 to $1,000.00 and set a “buy” rating on the stock in a report on Monday, April 6th. Leerink Partners restated an “outperform” rating and set a $1,085.00 price objective on shares of McKesson in a research report on Thursday, March 5th. Wall Street Zen upgraded shares of McKesson from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Raymond James Financial set a $970.00 price target on McKesson in a report on Thursday, March 5th. Finally, William Blair initiated coverage on McKesson in a report on Tuesday, April 28th. They set an “outperform” rating on the stock. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $960.53.

McKesson Trading Up 0.9%

MCK stock opened at $786.55 on Wednesday. The firm has a 50-day moving average of $794.00 and a two-hundred day moving average of $844.72. McKesson Corporation has a one year low of $637.00 and a one year high of $999.00. The firm has a market capitalization of $92.09 billion, a PE ratio of 20.45, a P/E/G ratio of 1.28 and a beta of 0.31.

McKesson (NYSE:MCK) last announced its earnings results on Thursday, May 7th. The company reported $11.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $11.56 by $0.13. The company had revenue of $96.30 billion for the quarter, compared to the consensus estimate of $101.35 billion. McKesson had a net margin of 1.18% and a negative return on equity of 345.35%. The company’s revenue was up 6.0% on a year-over-year basis. During the same period in the previous year, the business earned $10.12 EPS. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. On average, equities research analysts anticipate that McKesson Corporation will post 44.28 earnings per share for the current year.

McKesson Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 1st. Shareholders of record on Monday, June 1st will be paid a $0.82 dividend. This represents a $3.28 annualized dividend and a yield of 0.4%. The ex-dividend date is Monday, June 1st. McKesson’s dividend payout ratio is currently 8.53%.

Insider Activity at McKesson

In related news, EVP Michele Lau sold 3,550 shares of the firm’s stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $761.09, for a total transaction of $2,701,869.50. Following the transaction, the executive vice president owned 3,247 shares of the company’s stock, valued at approximately $2,471,259.23. This trade represents a 52.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Brian S. Tyler sold 4,929 shares of the firm’s stock in a transaction on Tuesday, June 9th. The shares were sold at an average price of $763.00, for a total transaction of $3,760,827.00. Following the transaction, the chief executive officer owned 22,845 shares in the company, valued at $17,430,735. This represents a 17.75% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 11,822 shares of company stock valued at $8,986,212. 0.08% of the stock is owned by insiders.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.